This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aorticvalve system (Xcor system, Saint Medical Technology, Inc., of patients showedmild paravalvular leakage, and all 125 (100%) patients were in New York Heart Association ClassII.
Quadricuspid aorticvalve (QAV) is rare. However, to repair a quadricuspid aorticvalve is not as easy to realize as in bicuspidaorticvalve. The surgical design is crucial to rebuild the stable structure.
BACKGROUND:Data concerning the outcomes of transcatheter aorticvalve replacement in type 0 bicuspidaortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2% 2.44];P=0.035).
TricuspidValve Repair Existing literature on national surgical outcomes of isolated tricuspidvalve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspidvalve surgery from 2017 to 2023 revealed a 5.5%
Objectives This study evaluates predictors of conduction abnormalities (CA) following transcatheter aorticvalve implantation (TAVI) in patients with bicuspidaorticvalves (BAV). Predictors of CA are well established among patients with tricuspidaorticvalves but not in those with BAV.
BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aorticvalve replacement (SAVR) in patients with bicuspidaorticvalve (BAV) aortic stenosis (AS) versus patients with tricuspidaorticvalve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).
Patients with bicuspidaorticvalves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aorticvalve replacement (TAVR) versus surgical aorticvalve replacement (SAVR) in patients with BAV.
Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aorticvalve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The proportion of SAVR patients increased in the <65yr patient group (26.2%
Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aorticvalve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. ±15.8 ±15.1 mm Hg, p value: 0.0079). to 84.7%) and 74.6% (95% CI 65.9%
Focusing on mitral and tricuspidvalve diseases , Capstans treatment combines transcatheter implantation of a folded valve replacement with its X-ray and ultrasound-guided robot to align the low-profile implant with the beating heart valve.
Standalone performance for significant major valve disease pathology (aortic stenosis and regurgitation and mitral and tricuspid regurgitation) had a 93 percent sensitivity and 93 percent specificity.
Background Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspidvalves. It is unknown whether MI also induces pathological remodelling of the aorticvalve and alters aortic stenosis (AS) progression. vs –0.04±0.04 cm 2 /m 2 /year; p=0.004).
Approximately one third (17 patients) had a heart problem identified using conventional in person echocardiography, including 10 with a primary diagnosis of valvulopathy (1 Barlow's syndrome, 1 bicuspidaorticvalve and 8 less-than-moderate regurgitation), 2 cardiac surgery follow-ups (1 case of aorticvalve replacement and septal myectomy, and 1 case (..)
Tracing in the lower part is tissue Doppler imaging from the medial mitral annulus. Opening and closing movements of the aortic and mitralvalves are visible. Slight downward angulation of the transducer from this view gives the left ventricular cross section with mitralvalve cross section within.
We are blessed with 4 heart valves – 2 on the left side which are known as the mitral and aorticvalves and 2 on the right side – the tricuspid and pulmonary valves.
Objective Variants in the FLNA gene have been associated with mitralvalve dystrophy (MVD), and even polyvalvular disease has been reported. This study aimed to analyse the aorticvalve and root involvement in FLNA -MVD families and its impact on outcomes. –6.1) –4.9) mm Hg, p=0.02). –6.1) –4.9)
Introduction Bicuspidaorticvalve (BAV) is the most common congenital heart disease with an increased risk of infective endocarditis (IE). The aim of this study was to compare patients with tricuspidaorticvalve (TAV) IE and BAV-IE in terms of characteristics, management and prognosis. IQR: 19–120] months.
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. and Lynn C.
Methods Moderate MAVD was defined as coexisting moderate aortic stenosis (aorticvalve area (AVA) 1.0–1.5 cm 2 ) and moderate aortic regurgitation (vena contracta (VC) 0.3–0.6 Identifying markers of haemodynamic severity will improve risk stratification and potentially guide timely treatment. –1.5
Objective CT aorticvalve calcium score (AVC score ) and density (AVC density ) thresholds have been recommended for aortic stenosis (AS) severity assessment in tricuspidaorticvalve (TAV). We aimed to compare AVC score and AVC density in bicuspidaorticvalve (BAV) versus TAV.
Background Bicuspidaorticvalve (BAV) is often associated with a concomitant aortopathy. However, few studies have evaluated the effect of the aorticvalve (AV) phenotype on the rate of dilation of the aorta.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
AF, atrial fibrillation; LAVI, left atrial volume index; RA, right atrial; RV, right ventricular; sPAP, systolic pulmonary artery pressure; SVI, stroke volume index; TR, tricuspid regurgitation. Aims Paradoxical low-flow, low-gradient aortic stenosis (pLFLG AS) may represent a diagnostic challenge, and its pathophysiology is complex.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content